AI assistant
ILLUMINA, INC. — Director's Dealing 2021
Jun 14, 2021
30440_dirs_2021-06-14_f6a272a1-29ba-4006-9f35-a5614d0b554e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ILLUMINA, INC. (ILMN)
CIK: 0001110803
Period of Report: 2021-06-11
Reporting Person: Febbo Phillip G. (SVP Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-11 | Common Stock | S | 310 | $446.17 | Disposed | 5151 | Direct |
| 2021-06-11 | Common Stock | S | 400 | $447.65 | Disposed | 4751 | Direct |
| 2021-06-11 | Common Stock | S | 290 | $449.02 | Disposed | 4461 | Direct |
Footnotes
F1: The sale was made pursuant to a 10b5-1 plan.
F2: Weighted average sale price representing 310 shares sold ranging from $446.14 to $446.24 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
F3: Weighted average sale price representing 400 shares sold ranging from $447.28 to $448.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.